Citation Impact
Citing Papers
Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma
2005 Standout
The use of mRNA display to select high-affinity protein-binding peptides
2001 StandoutNobel
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
1998 Standout
The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity
2017
Hypoxia — a key regulatory factor in tumour growth
2002 Standout
Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality
2009 StandoutNobel
Shedding light onto live molecular targets
2003 Standout
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
Improving the efficacy of antibody-based cancer therapies
2001
Small binding proteins selected from a combinatorial repertoire of knottins displayed on phage
1998 StandoutNobel
Design of metal-binding green fluorescent protein variants
1998
Targeting by affinity–matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform
1997 StandoutNobel
Retargeting serum immunoglobulin with bispecific diabodies
1997 StandoutNobel
A New Twist in TCR Diversity Revealed by a Forbidden αβ TCR
2007 StandoutNobel
PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake
2018 StandoutNobel
New approaches to antibody therapy
2000
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
Designing and optimizing library selection strategies for generating high-affinity antibodies
1997
Exploiting altered glycosylation patterns in cancer: Progress and challenges in diagnosis and therapy
1994
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
2006 Standout
High avidity scFv multimers; diabodies and triabodies
1999
Exploiting tumour hypoxia in cancer treatment
2004 Standout
[5] Screening of phage antibody libraries
1996 StandoutNobel
Glycans in cancer and inflammation — potential for therapeutics and diagnostics
2005 StandoutNobel
Gene transfer of antisense hypoxia inducible factor-1 α enhances the therapeutic efficacy of cancer immunotherapy
2001
Elimination of large tumors in mice by mRNA-encoded bispecific antibodies
2017 StandoutNobel
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Antibody phage display technology and its applications
1998
Metabolic Labeling of Sialic Acids in Living Animals with Alkynyl Sugars
2009 StandoutNobel
The biology of the combretastatins as tumour vascular targeting agents
2002
Human Antibodies with Sub-nanomolar Affinities Isolated from a Large Non-immunized Phage Display Library
1996
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Construction of di-scFv through a trivalent alkyne–azide 1,3-dipolar cycloaddition
2006
Calmodulin as a Versatile Tag for Antibody Fragments
1995 StandoutNobel
Application of Nanotechnology in Cancer Therapy and Imaging
2008
Chemistry in living systems
2005 StandoutNobel
Recombinant Human Single Chain Fv Antibodies Recognizing Human Interleukin-6
1998 StandoutNobel
The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues
1999
High-affinity recombinant phage antibodies to the pan-carcinoma marker epithelial glycoprotein-2 for tumour targeting
1998
Microtubules as a target for anticancer drugs
2004 Standout
Expression of an antibody fragment at high levels in the bacterial cytoplasm
1998 StandoutNobel
Enzyme immunoassays using bispecific diabodies
1997 StandoutNobel
Radioactive labeling of recombinant antibody fragments by phosphorylation using human casein kinase II and [γ-32P]-ATP
1996 StandoutNobel
Mammalian cell–based optimization of the biarsenical-binding tetracysteine motif for improved fluorescence and affinity
2005 StandoutNobel
Synthetic human antibodies and a strategy for protein engineering
1998 StandoutNobel
Complement recruitment using bispecific diabodies
1997 StandoutNobel
Arming antibodies: prospects and challenges for immunoconjugates
2005
Biotechnological applications of phage and cell display
2001
A strategy for the isolation of catalytic activities from repertoires of enzymes displayed on phage 1 1Edited by J. Karn
1999 StandoutNobel
Renal clearance of quantum dots
2007 StandoutNobel
Inhibition of Papillomavirus Protein Function in Cervical Cancer Cells by Intrabody Targeting
2005 StandoutNobel
Towards the Design of an Antibody that Recognises a Given Protein Epitope
1999 StandoutNobel
SuFEx Click Chemistry Enabled Late-Stage Drug Functionalization
2018 StandoutNobel
Efficient Cancer Therapy with a Nanobody-Based Conjugate
2004
Carcinoembryonic antigen (CEA)-specific T-cell activation in colon carcinoma induced by anti-CD3 x anti-CEA bispecific diabodies and B7 x anti-CEA bispecific fusion proteins.
1999 StandoutNobel
RNA-peptide fusions for the in vitro selection of peptides and proteins
1997 StandoutNobel
Vascular Targeting Agents as Cancer Therapeutics
2004
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
2009 Standout
Pathophysiologic Effects of Vascular-Targeting Agents and the Implications for Combination with Conventional Therapies
2006
SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models.
2003
High-Avidity Monoclonal Antibodies against the Human Scavenger Class B Type I Receptor Efficiently Block Hepatitis C Virus Infection in the Presence of High-Density Lipoprotein
2007 StandoutNobel
Drug Discovery: A Historical Perspective
2000 StandoutScience
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
Monoclonal Antibody Therapy for Cancer
2003
Monoclonal antibody-based therapies of leukemia and lymphoma
1992
Chimeric Antigen Receptor Therapy
2018 Standout
Potentiometric sensors based on surface molecular imprinting: Detection of cancer biomarkers and viruses
2010
Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients.
1991
Effects of 5,6-Dimethylxanthenone-4-Acetic Acid on Human Tumor Microcirculation Assessed by Dynamic Contrast-Enhanced Magnetic Resonance Imaging
2002
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Emerging Targets in Photopharmacology
2016 StandoutNobel
Cu-Catalyzed Azide−Alkyne Cycloaddition
2008 StandoutNobel
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Genetically engineered tetravalent single-chain Fv of the pancarcinoma monoclonal antibody CC49: improved biodistribution and potential for therapeutic application.
2000
Molecular imprinting: perspectives and applications
2016 Standout
Works of P A Keep being referenced
Ablation of colorectal xenografts with combined radioimmunotherapy and tumor blood flow-modifying agents.
1996
The effect of second antibody clearance on the distribution and dosimetry of radiolabelled anti‐cea antibody in a human colonic tumor xenograft model
1989
Purification of bacterially expressed single chain Fv antibodies for clinical applications using metal chelate chromatography
1995
Clinical evidence of efficient tumor targetting based on single–chain Fv antibody selected from a combinatorial library
1996
Extended Glycoprotein Structure of the Seven Domains in Human Carcinoembryonic Antigen by X-ray and Neutron Solution Scattering and an Automated Curve Fitting Procedure: Implications for Cellular Adhesion
1996
Phage libraries for generation of clinically useful antibodies
1994 StandoutNobel
Technetium-99m radiolabeling using a phage-derived single-chain Fv with a C-terminal cysteine.
1996
LIPOSOMALLY ENTRAPPED SECOND ANTIBODY IMPROVES TUMOUR IMAGING WITH RADIOLABELLED (FIRST) ANTITUMOUR ANTIBODY
1982